These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10523554)

  • 1. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.
    Hakanen A; Kotilainen P; Jalava J; Siitonen A; Huovinen P
    J Clin Microbiol; 1999 Nov; 37(11):3572-7. PubMed ID: 10523554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
    Albayrak F; Cokca F; Erdem B; Aysev AD
    Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S; Erdem B; Hasçelik G; Gür D
    Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.
    Piddock LJ; Ricci V; McLaren I; Griggs DJ
    J Antimicrob Chemother; 1998 Jun; 41(6):635-41. PubMed ID: 9687102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
    Hakanen AJ; Lindgren M; Huovinen P; Jalava J; Siitonen A; Kotilainen P
    J Clin Microbiol; 2005 Nov; 43(11):5775-8. PubMed ID: 16272517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH; Khan MA
    J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
    Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.
    Lunn AD; Fàbrega A; Sánchez-Céspedes J; Vila J
    Int Microbiol; 2010 Mar; 13(1):15-20. PubMed ID: 20890836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.
    Hakanen A; Kotilainen P; Huovinen P; Helenius H; Siitonen A
    Emerg Infect Dis; 2001; 7(6):996-1003. PubMed ID: 11747728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluroquinolone resistance in typhoidal Salmonella and its detection by nalidixic acid disc diffusion.
    Anjum P; Qureshi AH; Rafi S
    J Pak Med Assoc; 2004 Jun; 54(6):295-301. PubMed ID: 15366793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
    Marimón JM; Gomáriz M; Zigorraga C; Cilla G; Pérez-Trallero E
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3789-93. PubMed ID: 15388435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
    Irfan S; Jabeen K; Jilani UA; Ahmed B; Mehraj J; Ahsan T; Zafar A
    J Infect Dev Ctries; 2012 Oct; 6(10):700-3. PubMed ID: 23103891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
    Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.